Department of Radiology, Emory University, Atlanta, GA, USA.
Acad Radiol. 2013 Sep;20(9):1091-8. doi: 10.1016/j.acra.2013.05.006.
The aims of the study were: 1) to assess the baseline health-related quality of life (HRQOL) of patients with coronary artery disease (CAD) using the standard gamble; 2) to evaluate and compare patients' preference for catheter versus computed tomography (CT) coronary angiography using the wait tradeoff (WTO) and rating scales; and 3) to calculate test disutility for catheter and CT coronary angiography.
Thirty patients with CAD who underwent both CT and catheter angiography were interviewed by telephone within 6 months of testing. Patients were asked about their baseline symptoms and quality of life, their experience preparing for both CT and catheter angiography, their desire to undergo CT or catheter angiography, and immediate treatment versus having a waiting period between test results and treatment for a hypothetical "ideal test" with no side effects. Test disutility for CT and catheter angiography were calculated and compared.
The mean and median baseline HRQOL utility values were 0.72 and 0.91. The patients were willing to wait a mean (median) time of 12 (3) days after the ideal test for the test results to avoid undergoing CT angiography. They were willing to wait a mean (median) of 7 (3) days after the ideal test for test results, to avoid undergoing catheter angiography. There was no significant difference between waiting times or between patients' rating for their experience preparing for the two tests. Test disutility for CT angiography was 1.30 quality-adjusted life days (QALD) versus 2.16 QALD for catheter angiography (P > .05).
There was no significant difference in patient preference and test disutility between CT and catheter angiography in our small series. Future rigorously planned and adequately powered studies are required to confirm these findings in larger patient populations.
本研究的目的是:1)使用标准博弈评估冠心病患者的基线健康相关生活质量(HRQOL);2)使用等待权衡(WTO)和评分量表评估并比较患者对导管与计算机断层扫描(CT)冠状动脉造影的偏好;3)计算导管和 CT 冠状动脉造影的检验不适。
在检测后 6 个月内,通过电话对 30 名接受过 CT 和导管血管造影的 CAD 患者进行了访谈。询问了患者的基线症状和生活质量、为 CT 和导管血管造影做准备的经验、对 CT 或导管血管造影的愿望,以及在“理想试验”中有无副作用的情况下,对立即治疗与在获得试验结果和治疗之间等待一段时间的需求。计算并比较了 CT 和导管血管造影的检验不适。
平均和中位数基线 HRQOL 效用值分别为 0.72 和 0.91。患者愿意在理想试验后平均(中位数)等待 12(3)天,以避免进行 CT 血管造影。他们愿意在理想试验后平均(中位数)等待 7(3)天,以避免进行导管血管造影。等待时间或患者对两种检查准备的评分之间无显著差异。CT 血管造影的检验不适为 1.30 个质量调整生命日(QALD),而导管血管造影为 2.16 QALD(P>0.05)。
在我们的小系列中,CT 和导管血管造影在患者偏好和检验不适方面没有显著差异。需要未来进行严格计划和充分力量的研究,以在更大的患者群体中证实这些发现。